unknown by Murkin, John M.
LETTERS TO THE EDITOR 
Influence of perfusion technique and pH 
management strategy during coronary artery 
bypass surgery 
To the Editor." 
In a "double-blind," randomized study of 316 patients, 
which compared two methods of perfusion techniques 
(nonpulsatile vs pulsatile) and pH management (alpha- 
stat versus pH-stat), Murkin and colleagues I report that 
pulsatile perfusion resulted in a highly significant reduc- 
tion in myocardial infarction, death, the need for an 
intraaortic balloon pump, and major complications. These 
dramatic conclusions are significantly flawed, however, 
both by fundamental limitations in the study design and by 
the particularly high mortality and morbidity in the non- 
pulsatile group: 
The operations were performed by four surgeons, two 
of whom used crystalloid cardioplegia nd two of whom 
used blood cardioplegia (we are not told of the route of 
administration of the latter). The fact that the four 
surgeons performed 94, 99, 21, and 102 operations intro- 
duces a further major difference between the groups, 
because simple calculation reveals that between 36% and 
39% of patients must have received one type of cardio- 
plegia and 64% to 61% of patients the other. To compli- 
cate matters even further, the surgeons using crystalloid 
cardioplegia performed significantly more grafts with sig- 
nificantly shorter crossclamp times (by approximately 20 
minutes) than those using blood cardioplegia. Despite the 
highly significant differences in cardioplegic techniques, 
number of grafts, and duration of ischemia in the two 
groups, which are all major independent determinants of
cardiac morbidity, the authors merely state, without pro- 
viding any objective data, that "eardioplegia type did not 
correlate with adverse outcome." 
The use of the term "double-blind" in the abstract is 
totally misleading. The four operating surgeons must have 
been aware both of the mode of perfusion (by observation 
of analog displays of arterial pulse pressure) and the type 
of cardioplegic solution administered. If so, it is conceiv- 
able that individual surgeons were influenced, albeit sub- 
consciously, in the number of grafts they performed (as 
indeed was the case for surgeons using crystalloid cardio- 
plegia) or the need for an intraaortic balloon pump. The 
fact that the research nurse and technician were blinded 
to the mode of perfusion is irrelevant with regard to the 
collection of objective data such as the number of patients 
who died, who had electrocardiographicaIly confirmed 
infarcts, or who required intraaortic balloon pumps. 
A further major concern in this study is the particularly 
high mortality and morbidity in the nonpulsatile group 
considering their favorable demographic features (their 
mean age was 61 years, and 95% had a left ventricular 
ejection fraction >35%). A mortality of 6% and a require- 
ment for an intraaortic balloon pump in 7% of such 
good-risk elective patients appears particularly excessive 
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and is unlikely to be simply explained by the use of 
nonpulsatile perfusion. 
Although the authors are to be congratulated on un- 
dertaking a potentially important clinical trial, major 
reservations regarding their conclusions must remain until 
objective data are presented to eliminate the effects of 
different surgeons, cardioplegic techniques, number of 
grafts, and ischemic times on postoperative cardiac mor- 
tality and morbidity. Furthermore, the possibility that the 
apparent benefit of pulsatile perfusion was simply due to 
an excessively high mortality in the nonpulsatile group for 
some other reason must remain a genuine concern. 
David P. Taggart, MD(Hons), FRCS 
Oxford Heart Centre 
John Radcliffe Hospital 
Headington 
Oxford OX3 9DU, United Kingdom 
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Reply to the Editor: 
On behalf of my coauthors I would like to thank Dr. 
Taggart for his insightful analysis of our paper "A Ran- 
domized Study of the Influence of Perfusion Technique 
and pH Management S rategy in 316 Patients Undergoing 
Coronary Bypass Surgery. I. Mortality and Cardiovascular 
Morbidity." He has identified a number of contentious 
issues regarding the study design, and he raises concern 
regarding overall morbidity and mortality rates in the 
nonpulsatile group. 
With regard to study design, we agree with Dr. Taggart 
that the very real differences in composition of cardiople- 
gic solutions, route of administration (one surgeon used 
blood cardioplegia administered retrogradely, n = 21; the 
other three administered the cardioplegic solution antero- 
gradely), number of grafts, and duration of crossclamp 
between cardioplegia types (blood versus crystalloid), if 
controlled for, might be expected to result in differences in 
outcome across cardioplegia groups. It is precisely be- 
cause of these many uncontrolled variables, however, that 
cardioplegic type was not significant in outcome (page 
343: death, myocardial infarction, arrhythmia, and inser- 
tion of an intraaortic balloon pump vs cardioplegia type, 
univariate analysis, p = 0.11). More grafts and shorter 
crossclamp times were associated with use of crystalloid 
cardioplegia. Usage of blood cardioplegia was associated 
with the converse, but presumably enabled a longer 
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ischemic time (crossclamp time) to be tolerated without 
increasing myocardial morbidity, thus resulting in no 
difference in outcome between cardioplegia groups. 
It is also important to recognize, however, that surgical 
technique, encompassing all the variables of cardioplegia 
type, route of administration, number of grafts, and 
ischemic time, was controlled for by stratifying by surgeon 
(block design) the randomization ofpatients into pulsatile 
or nonpulsatile perfusion groups. As shown in Table II in 
the article, this powerful technique nsured equal distri- 
bution of these important parameters by the surgeon, thus 
enabling the crucial role of pulsatile perfusion to be 
unmasked. 
I must disagree with the characterization f the term 
"double-blind" as being "totally misleading." Although 
the type of perfusion may have been apparent o the 
personnel in the operating room, the nurse specialist 
assigned to identify adverse outcomes was blinded to 
treatment group. Such blinding of observers i not irrele- 
vant, even when absolutely objective end points such as 
mortality are used. Blinding becomes even more relevant 
when potentially contentious i sues such as diagnosis of 
postoperative myocardial infarction are involved. 
The specific concern that the decision regarding num- 
ber of coronary grafts to be performed or that the need to 
use an intraaortic balloon pump could be influenced, 
either subconsciously or overtly, by knowledge of cardio- 
pulmonary bypass perfusion type (pulsatile or nonpulsa- 
tile) is simply implausible. Before unblinding of these 
results, the four operating surgeons indicated no prefer- 
ence, either overt or covert, regarding cardiopulmonary 
bypass perfusion type. The claim that such knowledge did 
influence "the number of grafts they performed (as indeed 
was the case for surgeons using crystalloid cardioplegia)" 
is completely misleading and entirely incorrect. 
The concern that mortality (5.1%) and morbidity (in- 
sertion of intraaortic balloon pump in 7%) rates in the 
nonpulsatile group appear "particularly excessive" in such 
"good-risk elective patients" appears reasonable. In fact, 
however, of the eight deaths in the nonpulsatile group, 
two were due to massive cerebrovascular accident caused 
by cerebral emboli and unrelated to primary myocardial 
dysfunction. Furthermore, of the other six patients dying, 
two had very low ejection fractions (<15%) before the 
operation (one of whom was having a reoperation) and 
two other patients were in coronary care before the 
operation, requiring hemodynamic support and anticoag- 
ulation. The subset of patients dying of myocardial isch- 
emia was thus at much higher risk than would be pre- 
dicted from looking at mean data for the group as a whole. 
Again, the main strength of this study is that patients were 
randomized and assigned to treatment groups in a blinded 
fashion. Moreover, there were no intraoperative cross- 
overs. 
A very real limitation of this study remains: patients 
were not stratified before the operation by cardiac risk 
into pulsatile or nonpulsatile groups. Despite this, as 
shown in Tables I and II in the article, post-hoc analysis 
assured as much as possible the equivalency of risk factors 
and that uncontrolled variables (ischemic times, number 
of grafts etc.) did not differ between groups. We are thus 
left with the striking result that in a randomized trial, 
block stratified by surgeon (and surgical technique), pul- 
satile perfusion was associated with a significantly lower 
risk of morbidity and mortality than was nonpulsatile 
perfusion. We completely agree that these "dramatic 
conclusions" warrant "major reservations" and fully sup- 
port the call for further objective clinical outcome data to 
confirm or refute these results. 
John M. Murkin, MD 
Professor of Anaesthesia 
University of Western Ontario 
London, Ontario, Canada 
12/8/71014 
Anomalous origin of the left coronary artery from 
the pulmonary artery: Is reconstruction of a 
double coronary artery system always necessary? 
To the Editor: 
In their article on anomalous origin of the left main 
coronary artery from the pulmonary artery (J THOP, AC 
CAROIOVASC SURG 1995;109:393-4), Chan, Hare, and Bux- 
ton rightly state that the optimal surgical strategy for 
correction of this malformation, especially in the older 
patient, is still not resolved. 
They also highlight what we believe is an important 
point, namely, the role of noncoronary collateral blood 
flow to the left coronary artery (LCA). The pathophysiol- 
ogy of anomalous left coronary artery from the pulmonary 
artery (ALCAPA) depends on the extent of development 
of routes of blood supply to the left ventricle and the 
alterations in pulmonary vascular resistance. Although 
many earlier reports mention development of collaterals 
between the right and left coronary systems (intercoro- 
nary collaterals) as being responsible for survival into 
adulthood, the possibility of other systemic blood vessels 
feeding the LCA in ALCAPA has not been reported. 
These vessels also enlarge enough to maintain antegrade 
flow into the LCA, especially in the subgroup of patients 
surviving into the second or third decade without symp- 
toms. 
Recently we operated on a 15-year-old symptom-free 
boy who was being examined because of a continuous 
murmur in the left third and fourth intercostal spaces 
parasternally, detected by his physician on a routine 
examination. The patient had no evidence of ischemia, 
ventricular hypertrophy, or left ventricular dysfunction on 
electrocardiography or echocardiography. Echocardiogra- 
play suggested, and cardiac catheterization a d angiocar- 
diography confirmed, the diagnosis of ALCAPA with a 
large left-to-right shunt and the patient underwent surgi- 
cal treatment. 
After establishing moderate hypothermic eardiopulmo- 
nary bypass with crystalloid cardioplegic arrest, we opened 
the pulmonary artery with the intention of performing an 
intrapulmonary tunnel (Takeuchi) procedure. However, 
we were surprised by a brisk backflow of arterial blood 
into the pulmonary artery from the LCA ostium. Electri- 
cal activity of the heart returned within a couple of 
minutes of administration of cardioplegic solution. 
